Questions about our products?
Find support or contact us.

LAST DAY FOR SUBSCRIPTION IN HELIOSPECTRA’S ONGOING RIGHTS ISSUE IS 19 NOVEMBER 2025

THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL OR DEMAND ADDITIONAL REGISTRATION OR OTHER MEASURES. PLEASE REFER TO “IMPORTANT INFORMATION” IN THE END OF THIS PRESS RELEASE.

Heliospectra AB (publ) (“Heliospectra” or the “Company”) informs that 19 November 2025 is the last day for subscription in the Company’s ongoing rights issue of shares, which was resolved by the Board of Directors on 29 September 2025 and approved by the extraordinary general meeting on 30 October 2025 (the “Rights Issue”). Subscription rights that are not exercised for subscription of shares in the Rights Issue will expire worthless.

The Rights Issue in summary
–        The Rights Issue comprises a maximum of 494,710,691 shares.
–        Upon full subscription, Heliospectra will receive approximately SEK 49.5 million before deduction of issue costs.
–        The subscription price is SEK 0.10 per share.
–        Those who on the record date of 3 November 2025 were registered in the share register as shareholders in Heliospectra received nine (9) subscription rights for each (1) held share.
–        Five (5) subscription rights entitle the holder to subscribe for one (1) new share in the Company.
–        Shareholders who choose not to participate in the Rights Issue will have their ownership diluted by up to approximately 64.3 percent.
–        The Company has received subscription undertaking of SEK 30 million, corresponding to approximately 60.6 percent of the Rights Issue.
–        The last day for subscription in the Rights Issue is 19 November 2025.
–        Complete terms and instructions for the Rights Issue can be found in the Annex IX information document that the Company published on 4 November 2025.
The information document and other information about the Rights Issue is available on the Company’s website, www.heliospectra.com, and on Aqurat Fondkommission AB’s website, www.aqurat.se.

Indicative time plan for the Rights Issue
The time plan below for the Rights Issue is preliminary and may be subject to change.

Subscription period 5 – 19 November 2025
Trading in paid subscribed shares (BTA) 5 November – 1 December 2025
Announcement of outcome of the Rights Issue 21 November 2025

Advisers
MAQS Advokatbyrå AB is legal adviser to the Company in connection with the Rights Issue and Aqurat Fondkommission AB acts as issuing agent.